70 related articles for article (PubMed ID: 10785596)
21. Update on Adrenal Tumours in 2017 World Health Organization (WHO) of Endocrine Tumours.
Lam AK
Endocr Pathol; 2017 Sep; 28(3):213-227. PubMed ID: 28477311
[TBL] [Abstract][Full Text] [Related]
22. Clinico-epidemiology of neuroblastoma in north east Egypt: A 5-year multicenter study.
Al-Tonbary Y; Badr M; Mansour A; El Safy U; Saeed S; Hassan T; Elashery R; Nofal R; Darwish A
Oncol Lett; 2015 Aug; 10(2):1054-1062. PubMed ID: 26622625
[TBL] [Abstract][Full Text] [Related]
23. Orbital Metastasis Is Associated With Decreased Survival in Stage M Neuroblastoma.
Harreld JH; Bratton EM; Federico SM; Li X; Grover W; Li Y; Kerr NC; Wilson MW; Hoehn ME
Pediatr Blood Cancer; 2016 Apr; 63(4):627-33. PubMed ID: 26599346
[TBL] [Abstract][Full Text] [Related]
24. Effects of the Cessation of Mass Screening for Neuroblastoma at 6 Months of Age: A Population-Based Study in Osaka, Japan.
Ioka A; Inoue M; Yoneda A; Nakamura T; Hara J; Hashii Y; Sakata N; Yamato K; Tsukuma H; Kawa K
J Epidemiol; 2016; 26(4):179-84. PubMed ID: 26548355
[TBL] [Abstract][Full Text] [Related]
25. Adult onset of ganglioneuroblastoma of the adrenal gland: case report and review of the literature.
Bolzacchini E; Martinelli B; Pinotti G
Surg Case Rep; 2015 Dec; 1():79. PubMed ID: 26380803
[TBL] [Abstract][Full Text] [Related]
26. High levels of polo-like kinase 1 and phosphorylated translationally controlled tumor protein indicate poor prognosis in neuroblastomas.
Ramani P; Nash R; Sowa-Avugrah E; Rogers C
J Neurooncol; 2015 Oct; 125(1):103-11. PubMed ID: 26318737
[TBL] [Abstract][Full Text] [Related]
27. High proliferation index, as determined by immunohistochemical expression of Aurora kinase B and geminin, indicates poor prognosis in neuroblastomas.
Ramani P; Sowa-Avugrah E; May MT
Virchows Arch; 2015 Sep; 467(3):319-27. PubMed ID: 26199132
[TBL] [Abstract][Full Text] [Related]
28. Prolonged progression-free survival after consolidating second or later remissions of neuroblastoma with Anti-G
Kushner BH; Ostrovnaya I; Cheung IY; Kuk D; Kramer K; Modak S; Yataghene K; Cheung NK
Oncoimmunology; 2015 Jul; 4(7):e1016704. PubMed ID: 26140243
[TBL] [Abstract][Full Text] [Related]
29. High phosphohistone H3 expression correlates with adverse clinical, biological, and pathological factors in neuroblastomas.
Ramani P; Taylor S; Miller E; Sowa-Avugrah E; May MT
J Histochem Cytochem; 2015 Jun; 63(6):397-407. PubMed ID: 25711230
[TBL] [Abstract][Full Text] [Related]
30. Epidemiological and clinical characteristics of neuroblastoma in southern iran.
Bordbar M; Tasbihi M; Kamfiroozi R; Haghpanah S
Iran J Ped Hematol Oncol; 2014; 4(3):89-96. PubMed ID: 25254086
[TBL] [Abstract][Full Text] [Related]
31. Targeting gastrin-releasing peptide suppresses neuroblastoma progression via upregulation of PTEN signaling.
Paul P; Qiao J; Kim KW; Romain C; Lee S; Volny N; Mobley B; Correa H; Chung DH
PLoS One; 2013; 8(9):e72570. PubMed ID: 24039782
[TBL] [Abstract][Full Text] [Related]
32. Association of age at diagnosis and genetic mutations in patients with neuroblastoma.
Cheung NK; Zhang J; Lu C; Parker M; Bahrami A; Tickoo SK; Heguy A; Pappo AS; Federico S; Dalton J; Cheung IY; Ding L; Fulton R; Wang J; Chen X; Becksfort J; Wu J; Billups CA; Ellison D; Mardis ER; Wilson RK; Downing JR; Dyer MA;
JAMA; 2012 Mar; 307(10):1062-71. PubMed ID: 22416102
[TBL] [Abstract][Full Text] [Related]
33. PROX1 lymphatic density correlates with adverse clinicopathological factors, lymph node metastases and survival in neuroblastomas.
Ramani P; Norton A; Somerville MS; May MT
J Neurooncol; 2012 Jul; 108(3):375-83. PubMed ID: 22382784
[TBL] [Abstract][Full Text] [Related]
34. Minimal disease detection in peripheral blood and bone marrow from patients with non-metastatic neuroblastoma.
Yáñez Y; Grau E; Oltra S; Cañete A; Martínez F; Orellana C; Noguera R; Palanca S; Castel V
J Cancer Res Clin Oncol; 2011 Aug; 137(8):1263-72. PubMed ID: 21706131
[TBL] [Abstract][Full Text] [Related]
35. k-Nearest neighbor models for microarray gene expression analysis and clinical outcome prediction.
Parry RM; Jones W; Stokes TH; Phan JH; Moffitt RA; Fang H; Shi L; Oberthuer A; Fischer M; Tong W; Wang MD
Pharmacogenomics J; 2010 Aug; 10(4):292-309. PubMed ID: 20676068
[TBL] [Abstract][Full Text] [Related]
36. Immunologic and therapeutic synergy of IL-27 and IL-2: enhancement of T cell sensitization, tumor-specific CTL reactivity and complete regression of disseminated neuroblastoma metastases in the liver and bone marrow.
Salcedo R; Hixon JA; Stauffer JK; Jalah R; Brooks AD; Khan T; Dai RM; Scheetz L; Lincoln E; Back TC; Powell D; Hurwitz AA; Sayers TJ; Kastelein R; Pavlakis GN; Felber BK; Trinchieri G; Wigginton JM
J Immunol; 2009 Apr; 182(7):4328-38. PubMed ID: 19299733
[TBL] [Abstract][Full Text] [Related]
37. Regression of orthotopic neuroblastoma in mice by targeting the endothelial and tumor cell compartments.
Fuchs D; Christofferson R; Stridsberg M; Lindhagen E; Azarbayjani F
J Transl Med; 2009 Mar; 7():16. PubMed ID: 19284605
[TBL] [Abstract][Full Text] [Related]
38. Unchanged incidence and increased survival in children with neuroblastoma in Denmark 1981-2000: a population-based study.
Schroeder H; Wacher J; Larsson H; Rosthoej S; Rechnitzer C; Petersen BL; Carlsen NL
Br J Cancer; 2009 Mar; 100(5):853-7. PubMed ID: 19223904
[TBL] [Abstract][Full Text] [Related]
39. Absence of polysialylated NCAM is an unfavorable prognostic phenotype for advanced stage neuroblastoma.
Korja M; Jokilammi A; Salmi TT; Kalimo H; Pelliniemi TT; Isola J; Rantala I; Haapasalo H; Finne J
BMC Cancer; 2009 Feb; 9():57. PubMed ID: 19222860
[TBL] [Abstract][Full Text] [Related]
40. Small round blue cell tumours: diagnostic and prognostic usefulness of the expression of B7-H3 surface molecule.
Gregorio A; Corrias MV; Castriconi R; Dondero A; Mosconi M; Gambini C; Moretta A; Moretta L; Bottino C
Histopathology; 2008 Jul; 53(1):73-80. PubMed ID: 18613926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
